Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04840589
Title Testing the Combination of ZEN003694 and Nivolumab With or Without Ipilimumab in Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors National Cancer Institute (NCI)
Indications

Advanced Solid Tumor

ovary epithelial cancer

Therapies

Ipilimumab + Nivolumab + ZEN-3694

Nivolumab + ZEN-3694

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.